Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Oxford Bioscience Partners
3150
Oxford Bioscience Partners
Suggest edits
Follow us
Also headquartered in Boston
General Electric
DraftKings
Bain Capital
Sophia
TA Associates
Wikibon
Zipcar
State Street
Battery Ventures
Bolt
Overview
News
Investments
12
Portfolio
Portfolio Tracker
Add info
CNBC Tech
Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average
Xconomy
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More
SiliconRepublic
How Amgen Dún Laoghaire is working on ‘conscious inclusion’
Bloomberg Technology
Amgen Sales Beat Estimates as Otezla Tested for Covid Treatment
SiliconRepublic
Watch: How Amgen is committed to diversity, inclusion and belonging
SiliconRepublic
How this biotech engineer became a training lead at Amgen
GeekWire
Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu
GeekWire
The search for a COVID-19 cure: Amgen and Adaptive Biotech partner in quest for new drug
Xconomy
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
the home of AI info
Amgen puts its foot down in shiny new South San Francisco hub as it reorganizes R&D ops
the home of AI info
Amgen to Cut Another 172 Jobs Following Layoff Announcement Earlier This Month
the home of AI info
Amgen chops 172 more staffers in R&D, operations and sales amid neuroscience exit, revenue ...
the home of AI info
Amgen plans to eliminate another 172 jobs
the home of AI info
Amgen cutting almost 150 jobs in Cambridge
the home of AI info
Amgen Ends Neuroscience Research, Cuts Staff in Cambridge
the home of AI info
Drugmaker Amgen cuts a quarter of its Kendall Square research staff
the home of AI info
Amgen And Neuroscience
DealStreetAsia
Amgen to pick up 20.5% stake in BeiGene to expand in China
the home of AI info
Amgen exits neuroscience research, cuts 180 US jobs
the home of AI info
Amgen Exits Neuroscience Research: The Good, Bad, And Ugly Of Biopharma
